Table 4.
P-values reflecting significant differences in fractal dimension between groups of non tumorous and tumorous circumanal glands.
| FD400X | |||||
|---|---|---|---|---|---|
| FD100X | NCG | CGA | CGE | WDCGC | PDCGC |
| NCG | 0.949743 | 0.001023 | 0.000189 | 0.000140 | |
| CGA | 0.685997 | 0.002729 | 0.000251 | 0.000150 | |
| CGE | 0.000843 | 0.012797 | 0.999663 | 0.279804 | |
| WDCGC | 0.000149 | 0.000507 | 0.989656 | 0.265397 | |
| PDCGC | 0.000138 | 0.000191 | 0.235540 | 0.318949 | |
FD400X, fractal dimension estimated from vimentin IHC micrographs taken at magnification 400X; FD100X, fractal dimension estimated from vimentin IHC micrographs taken at magnification 100X; NCG, normal circumanal glands; CGA, circumanal gland adenomas; CGE, circumanal gland epitheliomas; WDCGC, well differentiated circumanal gland carcinomas; PDCGC, poorly differentiated circumanal gland carcinomas. Significant P-values (P<0.05), determined by performing Tukey’s HSD test, are in italic.